Shawn Fernando uses Gyrolab xP to meet tight deadlines
Shawn Fernando, Senior Researcher, Bioanalytical Development, Morphotek, Exton, PA, USA, presented ‘Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Trials’ at the North American Gyrolab Seminar, 2012, USA.
The Bioanalytical Development group at Morphotek faced the task of running a pharmacokinetic (PK) assay on a large backlog of samples to meet the tight deadlines of a Phase III study. Their validated assay was limited in throughput.
Applying the Gyrolab™ platform, Morphotek achieved a sustainable ramp-up in Phase III PK analyses to meet their drug development goals.
You can read more about this application here.
Note: To view the presentation on full screen, press ‘full screen’ before starting the presentation. Use ‘Outline’ to view selected sections of the presentation.